Evidence map›Paper›PMID 15951337›Full record

ArticleJournal of medical genetics2006

Congenital heart defects and genetic variants in the methylenetetrahydroflate reductase gene.

C A Hobbs, S J James, A Parsian, P A Krakowiak, S Jernigan, J J Greenhaw, Y Lu, M A Cleves

Abstract readLetter
In one paragraph

Article in Journal of medical genetics, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. TheDiabetology & metabolic syndrome · 2019
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. NAT1, NOS3, and TYMS genotypes and the risk of conotruncal cardiac defects.Birth defects research. Part A, Clinical and molecular teratology · 2011
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

C A Hobbs
S J James
A Parsian
P A Krakowiak
S Jernigan
J J Greenhaw
Y Lu
M A Cleves

Funding

Genomic/Epigenomic Factors and Non-Syndromic Congenital Heart Defect Risk R01HD039054 · NICHD · ARKANSAS CHILDREN'S HOSPITAL RES INST · PI HOBBS, CHARLOTTE A · 2000 to 2016
$13.6M
EXTRAMURAL RES FACILITIES CONSTR PROJC06RR016517 · NCRR · ARKANSAS CHILDREN'S HOSP (LITTLE ROCK) · PI BURKS, ARVIL WESLEY · 2001 to 2002
$1.3M
NCRR NIH HHS 1C06 RR16517-01NCRR NIH HHS 3C06 RR16517-01S1NCRR NIH HHS C06 RR016517NICHD NIH HHS 5R01 HD39054-05NICHD NIH HHS R01 HD039054ODCDC CDC HHS U50/CCU613236-08
6 · The paper itself

Abstract

backgroundMost non-syndromic congenital heart defects (CHD) are caused by a complex interaction between maternal lifestyle factors, environmental exposures, and maternal and fetal genetic variants. Maternal periconceptional intake of folic acid containing vitamin supplements is reported to decrease the risk of CHD. The 677C-->T and 1298A-->C polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene decrease enzyme activity.

objectiveTo examine the relation between CHD and maternal and fetal MTHFR polymorphisms.

methods375 nuclear families were studied. The transmission/disequilibrium test was used to test for transmission distortion in complete triads. A log-linear approach was used to test for associations between CHD and maternal and offspring polymorphisms, and to estimate independently the contributions of maternal and fetal variants to relative risks. Haplotype frequencies were estimated and a haplotype transmission disequilibrium test carried out.

resultsThe 1298C allele was transmitted less often than expected (p = 0.0013). There was no distortion in the transmission of the 677T allele, neither was there evidence of a parent of origin effect in the transmission of either of the single nucleotide polymorphisms. The 677C-1298C haplotype was also transmitted less often than expected (p = 0.0020). The relative risk associated with inheriting one copy of the 1298C allele was 0.64 (95% confidence interval, 0.48 to 0.87) and the that associated with inheriting two copies of the 1298C allele, 0.38 (0.21 to 0.70).

conclusionsThe apparent protective effect of the MTHFR 1298C allele against CHD could have several explanations and further study is needed.

Indexed as

AllelesFolic AcidHaplotypesHeart Defects, CongenitalHumansInfant, NewbornLinkage DisequilibriumMethylenetetrahydrofolate Reductase (NADPH2)Polymorphism, GeneticFolic AcidMethylenetetrahydrofolate Reductase (NADPH2)

Identifiers

PMID15951337
PMCPMC2564637

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.